TNF blockers have been available to treat various inflammatory disorders since more than a decade. T cells and macrophages mainly express TNF and activate many cells through two types of receptors. Pharmaceutical companies developed two types of TNF blockers: soluble receptors and monoclonal antibodies. Understanding of differences of structure and function can explain divergence of efficacy or side effects. Etanercept has the best retention rate in rheumatic diseases, but is less or not effective in granulomatous diseases, such as inflammatory bowel diseases or uveitis. However, etanercept induces less tuberculosis infections than anti-TNF blocker monoclonal antibodies.
Etanercept - TNF receptor and IgG1 Fc fusion protein: is it different from other TNF blockers? / H. Marotte, R. Cimaz. - In: EXPERT OPINION ON BIOLOGICAL THERAPY. - ISSN 1471-2598. - 14:5(2014 May), pp. 569-572. [10.1517/14712598.2014.896334]
Etanercept - TNF receptor and IgG1 Fc fusion protein: is it different from other TNF blockers?
R. CimazUltimo
2014
Abstract
TNF blockers have been available to treat various inflammatory disorders since more than a decade. T cells and macrophages mainly express TNF and activate many cells through two types of receptors. Pharmaceutical companies developed two types of TNF blockers: soluble receptors and monoclonal antibodies. Understanding of differences of structure and function can explain divergence of efficacy or side effects. Etanercept has the best retention rate in rheumatic diseases, but is less or not effective in granulomatous diseases, such as inflammatory bowel diseases or uveitis. However, etanercept induces less tuberculosis infections than anti-TNF blocker monoclonal antibodies.File | Dimensione | Formato | |
---|---|---|---|
Etanercept TNF receptor and IgG1 Fc fusion protein is it different from other TNF blockers.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
385.73 kB
Formato
Adobe PDF
|
385.73 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.